Omada Health, Inc. (OMDA): Cost of Revenue
$89.27M
Year ended 2025-12-31
$97.61M
Trailing 12 months to 2026-09-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $89.27M | +33.4% | 2026-03-06, From 2025-01-01 |
| 2024-12-31 | $66.92M | +26.7% | 2026-03-06, From 2024-01-01 |
| 2023-12-31 | $52.81M | n/a | 2026-03-06, From 2023-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | 2025-12-31 | $89.27M | +33.4% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $129.37M | +16.5% |
| Vsee Health, Inc. (VSEE) | 2025-12-31 | $7.26M | +123.9% |
| EUDA Health Holdings Ltd (EUDA) | 2025-12-31 | $3.83M | +17.8% |
| Longduoduo Co Ltd (LDDD) | 2026-06-30 | $17.0K | -81.4% |
| Agape ATP Corp (ATPC) | 2025-12-31 | $686.0K | +21.7% |
Compare OMDA, WGS, VSEE, EUDA side by side · Screen every company in Services-Health Services ↗